Literature DB >> 23741011

Runx3 deficiency results in myeloproliferative disorder in aged mice.

Chelsia Qiuxia Wang1, Lena Motoda, Masanobu Satake, Yoshiaki Ito, Ichiro Taniuchi, Vinay Tergaonkar, Motomi Osato.   

Abstract

The RUNX family genes encode transcription factors that are involved in development and human diseases. RUNX1 is one of the most frequently mutated genes in human hematological malignancies and is a critical factor for the generation and maintenance of hematopoietic stem cells. Another Runx family gene, Runx3, is known to be expressed in hematopoietic cells. However, its involvement in hematopoiesis remains unclear. Here we show the hematopoietic phenotypes in Runx3 conditional knockout (KO) mice (Runx3(fl/fl);Mx1-Cre(+)): whereas young Runx3 KO mice did not exhibit any significant hematopoietic defects, aged Runx3 KO mice developed a myeloproliferative disorder characterized by myeloid-dominant leukocytosis, splenomegaly, and an increase of hematopoietic stem/progenitor cells (HSPCs). Notably, Runx3-deficient cells showed hypersensitivity to granulocyte-colony stimulating factor, suggesting enhanced proliferative and mobilization capability of Runx3-deficient HSPCs when stimulated. These results suggest that, besides Runx1, Runx3 also plays a role in hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23741011     DOI: 10.1182/blood-2012-10-460618

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Cbfb deficiency results in differentiation blocks and stem/progenitor cell expansion in hematopoiesis.

Authors:  C Q Wang; D W L Chin; J Y Chooi; W J Chng; I Taniuchi; V Tergaonkar; M Osato
Journal:  Leukemia       Date:  2014-11-05       Impact factor: 11.528

2.  The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells.

Authors:  Philipp B Staber; Pu Zhang; Min Ye; Robert S Welner; Elena Levantini; Annalisa Di Ruscio; Alexander K Ebralidze; Christian Bach; Hong Zhang; Junyan Zhang; Katrina Vanura; Ruud Delwel; Henry Yang; Gang Huang; Daniel G Tenen
Journal:  Blood       Date:  2014-09-03       Impact factor: 22.113

3.  Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder.

Authors:  Ansuman T Satpathy; Carlos G Briseño; Xiongwei Cai; Drew G Michael; Chun Chou; Sunnie Hsiung; Deepta Bhattacharya; Nancy A Speck; Takeshi Egawa
Journal:  Blood       Date:  2014-03-27       Impact factor: 22.113

4.  Early life lead exposure causes gender-specific changes in the DNA methylation profile of DNA extracted from dried blood spots.

Authors:  Arko Sen; Nicole Heredia; Marie-Claude Senut; Matthew Hess; Susan Land; Wen Qu; Kurt Hollacher; Mary O Dereski; Douglas M Ruden
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

Review 5.  Mouse models for core binding factor leukemia.

Authors:  D W L Chin; N Watanabe-Okochi; C Q Wang; V Tergaonkar; M Osato
Journal:  Leukemia       Date:  2015-07-13       Impact factor: 11.528

Review 6.  Emerging therapies for inv(16) AML.

Authors:  Sridevi Surapally; Daniel G Tenen; John A Pulikkan
Journal:  Blood       Date:  2021-05-13       Impact factor: 22.113

7.  Increased expression of RUNX3 inhibits normal human myeloid development.

Authors:  Ana Catarina Menezes; Rachel Jones; Alina Shrestha; Rachael Nicholson; Adam Leckenby; Aleksandra Azevedo; Sara Davies; Sarah Baker; Amanda F Gilkes; Richard L Darley; Alex Tonks
Journal:  Leukemia       Date:  2022-04-30       Impact factor: 12.883

8.  Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians.

Authors:  Ming Zhao; Jian Qin; Hanqi Yin; Yixin Tan; Wei Liao; Qian Liu; Shuangyan Luo; Min He; Gongping Liang; Yajing Shi; Qing Zhang; Wenjun Cai; Guangliang Yin; Yin Zhou; Jing Wang; Mengying Li; Yi Huang; Aiyun Liu; Haijing Wu; Zhiyong Zhang; Qianjin Lu
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

9.  Long noncoding RNA FAM3D-AS1 inhibits development of colorectal cancer through NF-κB signaling pathway.

Authors:  Ying Meng; Feng Yu
Journal:  Biosci Rep       Date:  2019-07-05       Impact factor: 3.840

10.  RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity.

Authors:  D W L Chin; M Sakurai; G S S Nah; L Du; B Jacob; T Yokomizo; T Matsumura; T Suda; G Huang; X-Y Fu; Y Ito; H Nakajima; M Osato
Journal:  Blood Cancer J       Date:  2016-01-08       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.